tiprankstipranks
Trending News
More News >
Neuroscientific Biopharmaceuticals Ltd. (AU:NSB)
ASX:NSB
US Market

Neuroscientific Biopharmaceuticals Ltd. (NSB) Financial Statements

Compare
6 Followers

Neuroscientific Biopharmaceuticals Ltd. Financial Overview

Neuroscientific Biopharmaceuticals Ltd.'s market cap is currently AU$46.56M. The company's EPS TTM is AU$-0.01; its P/E ratio is -11.90; Neuroscientific Biopharmaceuticals Ltd. is scheduled to report earnings on August 28, 2025, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueAU$ 0.00AU$ 2.21MAU$ 4.95MAU$ 0.00AU$ 958.77K
Gross ProfitAU$ -92.78KAU$ -91.34KAU$ -57.85KAU$ -64.92KAU$ 897.36K
Operating IncomeAU$ -1.92MAU$ -2.06MAU$ -6.12MAU$ -10.50MAU$ -4.22M
EBITDAAU$ -1.92MAU$ -1.80MAU$ -5.96MAU$ -10.37MAU$ -3.12M
Net IncomeAU$ -1.85MAU$ 324.21KAU$ -1.07MAU$ -10.44MAU$ -3.18M
Balance Sheet
Cash & Short-Term InvestmentsAU$ 7.27MAU$ 4.95MAU$ 4.91MAU$ 7.22MAU$ 14.16M
Total AssetsAU$ 16.96MAU$ 5.44MAU$ 5.29MAU$ 7.74MAU$ 14.83M
Total DebtAU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00
Net DebtAU$ -7.27MAU$ -4.95MAU$ -4.91MAU$ -7.22MAU$ -14.16M
Total LiabilitiesAU$ 149.22KAU$ 85.68KAU$ 597.36KAU$ 2.22MAU$ 223.41K
Stockholders' EquityAU$ 16.81MAU$ 5.35MAU$ 4.69MAU$ 5.52MAU$ 14.60M
Cash Flow
Free Cash FlowAU$ -941.33KAU$ 42.43KAU$ -2.30MAU$ -6.95MAU$ -2.63M
Operating Cash FlowAU$ -941.33KAU$ 44.25KAU$ -2.30MAU$ -6.94MAU$ -2.60M
Investing Cash FlowAU$ -36.04KAU$ -1.81KAU$ 0.00AU$ -3.87KAU$ -29.88K
Financing Cash FlowAU$ 3.29MAU$ 0.00AU$ 0.00AU$ 0.00AU$ 13.51M
Currency in AUD

Neuroscientific Biopharmaceuticals Ltd. Earnings and Revenue History

Neuroscientific Biopharmaceuticals Ltd. Debt to Assets

Neuroscientific Biopharmaceuticals Ltd. Cash Flow

Neuroscientific Biopharmaceuticals Ltd. Forecast EPS vs Actual EPS